Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 158

Results For "Drug"

3401 News Found

Cipla launches drone delivery of critical medicines in Himachal Pradesh
Supply Chain | September 27, 2023

Cipla launches drone delivery of critical medicines in Himachal Pradesh

Commenced operations in flood-affected Himachal Pradesh


India to launch National Policy on Research and Development and Innovation in Pharma-MedTech
Policy | September 26, 2023

India to launch National Policy on Research and Development and Innovation in Pharma-MedTech

Also to be launched Scheme for promotion of Research and Innovation in Pharma MedTech Sector (PRIP)


Biosergen, Alkem collaborate to develop anti-infective for severe fungal infections
News | September 26, 2023

Biosergen, Alkem collaborate to develop anti-infective for severe fungal infections

Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases


Briefs: Mankind Pharma and Sequent Scientific
News | September 26, 2023

Briefs: Mankind Pharma and Sequent Scientific

Mankind Pharma commences the commercial operations newly set-up plant in Udaipur


Strides receives USFDA approval for Icosapent Ethyl Capsules
Drug Approval | September 25, 2023

Strides receives USFDA approval for Icosapent Ethyl Capsules

The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)


Emmes appoints Peter Ronco as CEO
People | September 23, 2023

Emmes appoints Peter Ronco as CEO

Ronco succeeds Dr. Christine Dingivan, who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri


Natural Biogenex performs inauguration at Tumkur unit
News | September 22, 2023

Natural Biogenex performs inauguration at Tumkur unit

This production block consists of chemical synthesis reactions and clean rooms areas to produce final API


Zydus receives final approval from the USFDA for Clindamycin Phosphate Gel USP, 1%
Drug Approval | September 21, 2023

Zydus receives final approval from the USFDA for Clindamycin Phosphate Gel USP, 1%

Clindamycin Phosphate Gel is used to treat acne


USFDA conducts inspection at InvaGen manufacturing facility in Central Islip, NY, USA
Drug Approval | September 21, 2023

USFDA conducts inspection at InvaGen manufacturing facility in Central Islip, NY, USA

InvaGen has received 5 inspectional observations in Form 483


Venus Remedies gets marketing approval for gemcitabine and docetaxel in Serbia
News | September 21, 2023

Venus Remedies gets marketing approval for gemcitabine and docetaxel in Serbia

With this, the company has secured 511 marketing approvals for its oncology products across 66 countries